Stockholder Alert: Ademi LLP Continues Investigation of the Fairness of Landos Biopharma, Inc.'s Transaction With AbbVie
Stockholder Alert: Ademi LLP Continues Investigation of the Fairness of Landos Biopharma, Inc.'s Transaction With AbbVie
MILWAUKEE, April 16, 2024 /PRNewswire/ -- Ademi LLP investigation of Landos (NASDAQ: LABP) continues now that Landos has filed a preliminary proxy statement seeking stockholder approval for its transaction with AbbVie.
密爾沃基，2024年4月16日 /PRNewswire/ — 由於蘭多斯已提交初步委託書，尋求股東批准與艾伯維的交易，Ademi LLP對蘭多斯（納斯達克股票代碼：LABP）的調查仍在繼續。
Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
點擊此處了解如何加入或撥打 Guri Ademi 的免費電話 866-264-3995。您無需支付任何費用或承擔任何義務。
In the transaction, Landos shareholders will receive only $20.42 per share in cash upon closing, or approximately $137.5 million in the aggregate, plus one non-tradable contingent value right per share with a value of up to $11.14 per share, or approximately an additional $75 million in the aggregate, subject to the achievement of a clinical development milestone. The transaction agreement unreasonably limits competing transactions for Landos by imposing a significant penalty if Landos accepts a competing bid. Landos insiders will receive substantial benefits as part of change of control arrangements.
在這筆交易中，Landos的股東在交易完成時將僅獲得每股20.42美元的現金，合計約1.375億美元，外加每股一項不可交易的或有價值權利，每股價值最高爲11.14美元，總額約爲7,500萬美元，前提是臨床開發里程碑的實現。該交易協議不合理地限制了蘭多斯的競爭交易，如果蘭多斯接受競爭性出價，將處以巨額罰款。作爲控制權變更安排的一部分，Landos內部人士將獲得可觀的收益。
Landos has filed a preliminary proxy statement seeking stockholder approval, which requires further investigation.
蘭多斯已提交初步委託書，尋求股東批准，這需要進一步調查。
If you own Landos common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or
如果你擁有蘭多斯普通股並希望獲得更多信息，請致電 [email protected] 或免費電話：866-264-3995 與 Guri Ademi 聯繫，或
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
我們專門處理涉及收購、合併和全國各地個人股東權利的股東訴訟。欲了解更多信息，請隨時致電我們。律師廣告。先前的結果並不能保證類似的結果。
Contacts
聯繫人
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
Ademi LLP
Guri Ademi
免費電話：(866) 264-3995
傳真：(414) 482-8001
SOURCE Ademi LLP
來源 Ademi LLP
譯文內容由第三人軟體翻譯。